Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Kernicterus Treatment Market Size Changed, over the years?

In recent years, the market size for kernicterus treatment has been on a consistent rise. The market is expected to increase from $2.98 billion in 2024, hitting $3.06 billion in 2025 with a compound annual growth rate (CAGR) of 3.0%. Factors contributing to this growth over the historical period include advancements in neonatal care procedures, increased knowledge among healthcare professionals, governmental efforts towards maternal and child wellbeing, funding for research and clinical studies, and partnerships within the realm of medical research.

How Much Will the Kernicterus Treatment Market Be Worth in 2029?

The market size for kernicterus treatment is predicted to undergo steady expansion in the coming years, reaching up to $3.37 billion by 2029 with a compound annual growth rate (CAGR) of 2.4%. The expected growth within the forecast period is associated with multiple factors including continual medical education initiatives, implementation of global health policies, patient advocacy groups, collaborative international research in pediatrics, and government investments in neonatal health. Foreseen trends within this duration encompass progress in technologies for monitoring neonatal jaundice, release of advanced phototherapy equipment, creation of medications that reduce bilirubin, prioritising home-based phototherapy solutions, application of bilirubin nomograms and guidelines, and the incorporation of telehealth for distant patient monitoring.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13470&type=smp

Which is the Largest Company in the Kernicterus Treatment Market?

Major companies operating in the kernicterus treatment market report are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck and Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, AstraZeneca plc., Abbott Laboratories, Sanofi SA, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Johnson and Johnson Private Limited, Baxter International Inc., Grifols S.A, Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Alembic Pharmaceuticals Limited, Lupin Pharmaceuticals Inc., CSL Limited, Glenmark Pharmaceuticals Ltd., Cipla Inc., Torrent Pharmaceuticals Ltd., Octapharma Brasil Ltda, Kedrion S.p.A, Biotest AG, Wockhardt Ltd., Mylan N.V., Cadila Healthcare Ltd., Teva Pharmaceutical Industries Ltd., China Biologic Products Holdings Inc.

What Are the Main Market Drivers in the Kernicterus Treatment Industry?

The growth of the kernicterus treatment market is significantly bolstered by the common occurrence of neonatal jaundice. Neonatal jaundice, also referred to as jaundice in newborns, is a widespread, typically benign condition signified by a yellowish tinge to a baby’s skin and whites of their eyes. Treatment for kernicterus is regularly employed to deal with neonatal jaundice, managing its symptoms and providing supportive care. The treatment involves the removal of the baby’s blood, replacing it with blood that has less bilirubin level, thereby improving the child’s overall wellbeing. For instance, in October 2023, the US-based National Library of Medicine reported that approximately 60% of term and 80% of preterm infants suffer from jaundice within their first week of life. Additionally, it was found that around 10% of breastfed infants were still jaundiced by the end of their first month. Consequently, the commonness of neonatal jaundice lends itself to propelling kernicterus treatment market growth.

Kernicterus Treatment Market Driver: Expansion in Healthcare Expenditure Fuels Treatment Procedures

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=13470&type=smp

How Is the Kernicterus Treatment Market Segments Structured?

The kernicterus treatment market covered in this report is segmented –

1) By Treatment: Phototherapy, Intravenous Immunoglobulins (IVIG), Blood Transfusion, Medication, Other Treatments

2) By Symptoms: Jaundice, Unusual Eye Movements, Vomiting, Fever, Poor Feeding, Apnoea, Irritability, Seizures, Sleepiness, Other Symptoms

3) By Dosage: Injection, Solution, Other Dosages

4) By End-Users: Clinic, Hospital, Other End-Users

Subsegments:

1) By Phototherapy: Conventional Phototherapy, Fiberoptic Phototherapy, LED Phototherapy

2) By Intravenous Immunoglobulins (IVIG): Standard IVIG Therapy, High-Dose IVIG Therapy

3) By Blood Transfusion: Exchange Transfusion, Simple Transfusion

4) By Medication: Bilirubin-Lowering Agents, Antioxidants, Neuroprotective Agents

5) By Other Treatments: Supportive Care, Nutritional Support, Adjunct Therapies

What Strategic Trends Are Transforming the Kernicterus Treatment Market?

In an effort to expand their influence and gain a competitive advantage in the cornea treatment market, major institutes are strategically investing in partnerships. One such example is the UCL Department of Medical Physics and Biomedical Engineering, a UK-based institution known for its contributions to both research and education in the field of medical physics and biomedical engineering. In July 2024, this institution collaborated with UCL Hospitals to introduce NeoSCB, a smartphone app equipped to identify severe jaundice in newborns through an analysis of images of the sclera (the white part of the eye). This non-invasive screening method proves to be extremely advantageous in areas with limited resources where traditional jaundice screening devices may not be economically feasible. By determining the degree of yellowing in the sclera, the app effectively measures bilirubin levels in the bloodstream. Its accuracy rate is commendable as it successfully identified 74 out of 79 cases of severe jaundice in infants, this rate is on par with the efficiency of classical techniques like transcutaneous bilirubinometers that measure bilirubin through the skin.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/kernicterus-treatment-global-market-report

Which Global Regions Offer the Highest Growth in the Kernicterus Treatment Market?

North America was the largest region in the kernicterus treatment market in 2024. The regions covered in the kernicterus treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13470

This Report Delivers Insight On:

1. How big is the kernicterus treatment market, and how is it changing globally?

2. Who are the major companies in the kernicterus treatment market, and how are they performing?

3. What are the key opportunities and risks in the kernicterus treatment market right now?

4. Which products or customer segments are growing the most in the kernicterus treatment market?

5. What factors are helping or slowing down the growth of the kernicterus treatment market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model